These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23326561)

  • 1. H3N2v and other influenza epidemic risk based on age-specific estimates of sero-protection and contact network interactions.
    Skowronski DM; Moser FS; Janjua NZ; Davoudi B; English KM; Purych D; Petric M; Pourbohloul B
    PLoS One; 2013; 8(1):e54015. PubMed ID: 23326561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).
    Skowronski DM; Janjua NZ; De Serres G; Purych D; Gilca V; Scheifele DW; Dionne M; Sabaiduc S; Gardy JL; Li G; Bastien N; Petric M; Boivin G; Li Y
    J Infect Dis; 2012 Dec; 206(12):1852-61. PubMed ID: 22872731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants.
    Liu F; Veguilla V; Gross FL; Gillis E; Rowe T; Xu X; Tumpey TM; Katz JM; Levine MZ; Lu X
    J Infect Dis; 2017 Sep; 216(suppl_4):S539-S547. PubMed ID: 28934461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower seroreactivity to European than to North American H3N2 swine influenza viruses in humans, Luxembourg, 2010.
    Qiu Y; Muller CP; Van Reeth K
    Euro Surveill; 2015 Apr; 20(13):25-33. PubMed ID: 25860393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.
    Agrati C; Castilletti C; Cimini E; Lapa D; Quartu S; Caglioti C; Lanini S; Cattoli G; Martini F; Ippolito G; Capobianchi MR
    PLoS One; 2014; 9(8):e105651. PubMed ID: 25162670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis and Transmission of Genetically Diverse Swine-Origin H3N2 Variant Influenza A Viruses from Multiple Lineages Isolated in the United States, 2011-2016.
    Sun X; Pulit-Penaloza JA; Belser JA; Pappas C; Pearce MB; Brock N; Zeng H; Creager HM; Zanders N; Jang Y; Tumpey TM; Davis CT; Maines TR
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29848587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprotective antibodies to 2011 variant influenza A(H3N2v) and seasonal influenza A(H3N2) among three age groups of US Department of Defense service members.
    Radin JM; Hawksworth AW; Ortiguerra RG; Brice GT
    PLoS One; 2015; 10(3):e0121037. PubMed ID: 25816244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1.
    Kwok KO; Riley S; Perera RAPM; Wei VWI; Wu P; Wei L; Chu DKW; Barr IG; Malik Peiris JS; Cowling BJ
    BMC Infect Dis; 2017 May; 17(1):337. PubMed ID: 28494805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related prevalence of cross-reactive antibodies against influenza A(H3N2) variant virus, Germany, 2003 to 2010.
    Blümel B; Schweiger B; Dehnert M; Buda S; Reuss A; Czogiel I; Kamtsiuris P; Schlaud M; Poethko-Müller C; Thamm M; Haas W
    Euro Surveill; 2015 Aug; 20(32):16-24. PubMed ID: 26290488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009-2011.
    Nelson MI; Vincent AL; Kitikoon P; Holmes EC; Gramer MR
    J Virol; 2012 Aug; 86(16):8872-8. PubMed ID: 22696653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains.
    Chen LL; Wu WL; Chan WM; Fong CHY; Ng ACK; Ip JD; Lu L; Dissanayake TK; Ding X; Cai JP; Zhang AJX; Tam S; Hung IFN; Chan KH; Yuen KY; To KKW
    Epidemiol Infect; 2019 Sep; 147():e279. PubMed ID: 31556360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal patterns of influenza A subtypes and B lineages across age in a subtropical city, during pre-pandemic, pandemic, and post-pandemic seasons.
    Zhou L; Yang H; Kuang Y; Li T; Xu J; Li S; Huang T; Wang C; Li W; Li M; He S; Pan M
    BMC Infect Dis; 2019 Jan; 19(1):89. PubMed ID: 30683067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of variant influenza A(H3N2) virus in the United States.
    Jhung MA; Epperson S; Biggerstaff M; Allen D; Balish A; Barnes N; Beaudoin A; Berman L; Bidol S; Blanton L; Blythe D; Brammer L; D'Mello T; Danila R; Davis W; de Fijter S; Diorio M; Durand LO; Emery S; Fowler B; Garten R; Grant Y; Greenbaum A; Gubareva L; Havers F; Haupt T; House J; Ibrahim S; Jiang V; Jain S; Jernigan D; Kazmierczak J; Klimov A; Lindstrom S; Longenberger A; Lucas P; Lynfield R; McMorrow M; Moll M; Morin C; Ostroff S; Page SL; Park SY; Peters S; Quinn C; Reed C; Richards S; Scheftel J; Simwale O; Shu B; Soyemi K; Stauffer J; Steffens C; Su S; Torso L; Uyeki TM; Vetter S; Villanueva J; Wong KK; Shaw M; Bresee JS; Cox N; Finelli L
    Clin Infect Dis; 2013 Dec; 57(12):1703-12. PubMed ID: 24065322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using routine surveillance data to estimate the epidemic potential of emerging zoonoses: application to the emergence of US swine origin influenza A H3N2v virus.
    Cauchemez S; Epperson S; Biggerstaff M; Swerdlow D; Finelli L; Ferguson NM
    PLoS Med; 2013; 10(3):e1001399. PubMed ID: 23472057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2018 Aug; 36(33):5097-5103. PubMed ID: 30007825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population susceptibility to North American and Eurasian swine influenza viruses in England, at three time points between 2004 and 2011.
    Hoschler K; Thompson C; Casas I; Ellis J; Galiano M; Andrews N; Zambon M
    Euro Surveill; 2013 Sep; 18(36):pii=20578. PubMed ID: 24079379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Likelihood of prior exposure to circulating influenza viruses resulting in cross-protection by CD8+ T cells against emergent H3N2v swine viruses infecting humans.
    Komadina N; Sullivan SG; Leder K; McVernon J
    J Med Virol; 2022 Feb; 94(2):567-574. PubMed ID: 34449904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012.
    Epperson S; Jhung M; Richards S; Quinlisk P; Ball L; Moll M; Boulton R; Haddy L; Biggerstaff M; Brammer L; Trock S; Burns E; Gomez T; Wong KK; Katz J; Lindstrom S; Klimov A; Bresee JS; Jernigan DB; Cox N; Finelli L;
    Clin Infect Dis; 2013 Jul; 57 Suppl 1():S4-S11. PubMed ID: 23794729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
    Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D
    Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.